Elucid BioImaging Expands Executive Team with Appointment of John GarberJanuary 16, 2017
Wenham, MA (January 12th, 2017) — Elucid Bioimaging, Inc. (“Elucid”), a leader in quantitative medical imaging, is proud to announce the expansion of its executive team with the appointment of John T Garber, MBA, as Vice President of Sales and Business Development. John will strengthen Elucid’s operations and executive management and lead commercialization of their promising Computer Aided Phenotyping (CAP) applications that add quantitative insights to standard imaging tests.
“We are delighted to welcome John to Elucid,” said Andrew Buckler Msc, Founder and CEO of Elucid, “John is an established leader with a successful track record in commercializing new medical imaging processing technologies and developing strong market demand for them. John’s creative and energetic leadership will be essential as develop the market for our innovative image processing solutions in vascular, lung, kidney and other applications.”
John Garber has over 20 years of experience developing profitable markets for innovative technologies in telecom, e-commerce and medical imaging applications. He previously served as a co-founder and initial CEO of VIDA Diagnostics Inc, the gold standard for pulmonary imaging and most recently he was Vice President of Operations and Imaging Solutions, North America for Image Analysis Ltd, an innovative imaging CRO and technology company in the muscoskeletal and cancer spaces. John holds an MBA in Operations Management from the University of Chicago and a BA in Computer science from Yale.
“I’m excited to be joining Elucid’s executive team, “ said John, “The team has done a tremendous job developing and validating their Computer Aided Phenotyping technology and I am honored to play a role in its commercial development. “